9 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18419894 | ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF | RAHMANI, NILOOFAR | 1691 | Non-Final OA | Jan 23, 2024 |
| 18573723 | CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | VALLE, ERNESTO | 1623 | Non-Final OA | Dec 22, 2023 |
| 18557852 | PKC-Theta Modulators | RAO, PADMAJA S | 1627 | Final Rejection | Oct 27, 2023 |
| 18223768 | Heteroaryl Compounds as Ligand Directed Degraders of IRAK4 | VALLE, ERNESTO | 1623 | Non-Final OA | Jul 19, 2023 |
| 17995915 | METHODS FOR TREATING ANEMIA USING AN ACTRIIB LIGAND TRAP AND FEDRATINIB | BORGEEST, CHRISTINA M | 1675 | Final Rejection | Oct 10, 2022 |
| 17817777 | Composition and Methods for Selective Degradation of Engineered Proteins | BOWLES, DAVID PAUL | 1654 | Final Rejection | Aug 05, 2022 |
| 17867294 | ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME | NESTOR, DONNA MICHELLE | 1627 | Final Rejection | Jul 18, 2022 |
| 17776561 | PEDIATRIC FORMULATIONS FOR TREATMENT OF CANCER | COHEN, MICHAEL P | 1612 | Final Rejection | May 12, 2022 |
| 17075594 | METHODS FOR TREATING A HEMATOLOGICAL CANCER AND THE USE OF COMPANION BIOMARKERS FOR 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE | BUTTICE, AUDREY L | 1647 | Final Rejection | Oct 20, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial